Comprehensive dataset from A4 study yields key insights about Alzheimer’s disease

FHS
July 24, 2024
11:55 am

Data from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (A4) study, the first and largest clinical trial of pre-symptomatic Alzheimer’s disease, is now widely available to researchers studying the condition.

MSD’s sotatercept gains UK MHRA approval

January 2, 2025

OMNY Health Launches GLP-1 Data Network for Research

What You Should Know: – OMNY Health, a healthcare ecosystem specializing in data partnerships, today announced the launch of its GLP-1 data network. – The

August 27, 2024

Study Details Perinatal Risks of Blood Cancers Diagnosed in Pregnancy

Women diagnosed with hematologic cancers during pregnancy had increased risks for serious maternal morbidity and obstetric complications, according to results of a large observational study

October 12, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.